These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 12523079)
1. [Complete and independent scrutiny of coxiber is required]. Håkansson J Lakartidningen; 2002 Nov; 99(48):4904. PubMed ID: 12523079 [No Abstract] [Full Text] [Related]
2. [Financial interests characterize published reports on coxiber. Whom can we rely on?]. Håkansson J Lakartidningen; 2002 Oct; 99(40):3930-1. PubMed ID: 12422746 [No Abstract] [Full Text] [Related]
3. [Five turbulent years of coxibers. Where did the principle of caution go?]. Håkansson J; Rosenberg P Lakartidningen; 2005 May 2-15; 102(18-19):1432-4. PubMed ID: 15929426 [No Abstract] [Full Text] [Related]
4. [Vision impairment by COX-2 inhibitor and the sequelae of voluntary Vioxx recall]. Meyer CH Klin Monbl Augenheilkd; 2005 Jan; 222(1):62-3. PubMed ID: 15678404 [No Abstract] [Full Text] [Related]
5. [Celebra and the CLASS trial--a scandal!]. Lindberg M Ugeskr Laeger; 2002 Nov; 164(46):5407-8; author reply 5408. PubMed ID: 12469395 [No Abstract] [Full Text] [Related]
6. Was Vioxx really that dangerous? Park A Time; 2005 Feb; 165(9):52. PubMed ID: 15765852 [No Abstract] [Full Text] [Related]
7. "To do no harm". Binymin KA; Phillips K Rheumatology (Oxford); 2007 Feb; 46(2):368-70; author reply 370. PubMed ID: 17116655 [No Abstract] [Full Text] [Related]
8. [Pfizer urged to respond to criticism and participate in the public debate]. Bengt J Lakartidningen; 2005 Feb 21-27; 102(8):574-5. PubMed ID: 15786910 [No Abstract] [Full Text] [Related]
9. [The coxiber debate--but what about paracetamol?]. Gréen K Lakartidningen; 2003 Mar; 100(11):966-8. PubMed ID: 15148727 [No Abstract] [Full Text] [Related]
10. [COX-2 inhibitors--actually, why to use them?]. Lindberg M Lakartidningen; 2002 Nov; 99(48):4904-6. PubMed ID: 12523080 [No Abstract] [Full Text] [Related]
11. 'Guidelines' or marketing for non-steroidal anti-inflammatory drug and proton pump inhibitor use? Graham DY Aliment Pharmacol Ther; 2004 Jun; 19(12):1323-4; author reply 1325. PubMed ID: 15191515 [No Abstract] [Full Text] [Related]
12. FDA warning on NSAID use. FDA Consum; 2005; 39(2):5. PubMed ID: 16121416 [No Abstract] [Full Text] [Related]
13. [We must learn how to be better to evaluate drug benefits and risks]. Dahl E Lakartidningen; 2005 Jun 27-Jul 10; 102(26-27):2003-4. PubMed ID: 16044759 [No Abstract] [Full Text] [Related]
14. Research Ethics . In clear sight. de Andrade M BMJ; 2009 Sep; 339():b3443. PubMed ID: 19726462 [No Abstract] [Full Text] [Related]
15. Reduced incidence of upper gastrointestinal ulcer complications with the COX-2 selective inhibitor, valdecoxib. Goldstein JL; Eisen GM; Agrawal N; Stenson WF; Kent JD; Verburg KM Aliment Pharmacol Ther; 2004 Sep; 20(5):527-38. PubMed ID: 15339324 [TBL] [Abstract][Full Text] [Related]
16. Merck withdraws Vioxx; FDA issues public health advisory. FDA Consum; 2004; 38(6):11. PubMed ID: 15675020 [No Abstract] [Full Text] [Related]
17. [COX-2 inhibitors--can we rely on the articles?]. Lindberg M Ugeskr Laeger; 2002 Oct; 164(42):4945-6; author reply 4946. PubMed ID: 12416082 [No Abstract] [Full Text] [Related]
18. [A new interesting study on coxib]. Carlqvist M; Ohlén K Lakartidningen; 2003 Apr; 100(14):1261. PubMed ID: 12756658 [No Abstract] [Full Text] [Related]
19. Does the pro-hypertensive effect of cyclooxygenase-2 inhibitors account for the increased risk in cardiovascular disease? Messerli FH; Sichrovsky T Am J Cardiol; 2005 Sep; 96(6):872-3. PubMed ID: 16169380 [No Abstract] [Full Text] [Related]
20. Older people should NOT be prescribed 'coxibs' in place of conventional NSAIDs. Jüni P; Dieppe P Age Ageing; 2004 Mar; 33(2):100-4. PubMed ID: 14960422 [No Abstract] [Full Text] [Related] [Next] [New Search]